These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32005066)

  • 1. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.
    Chen HJ; Wang CG; Dou HL; Feng XF; Xu YM; Ma ZZ
    Ann Palliat Med; 2020 Jan; 9(1):82-89. PubMed ID: 32005066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.
    Yang KB; Zhang H; Li SJ; Cao JJ; Cheng LN; Lin YX; Tian ZC; Li J; Gu F; Liu ZL
    J Ocul Pharmacol Ther; 2019 Apr; 35(3):161-167. PubMed ID: 30668279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
    Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
    Li S; Yang Y; Zou J; Zeng J; Ding C
    BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients.
    Li S; Tang J; Han X; Wang Z; Zhang L; Zhao M; Qu J
    Ophthalmol Ther; 2022 Oct; 11(5):1833-1845. PubMed ID: 35904708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
    Pei M; Zhao X; Wan G
    Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
    di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
    Hu L; Chen Q; Du Z; Wang W; Zhao G
    Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.
    Yan Y; Zhu L; Hong L; Deng J; Song Y; Chen X
    Acta Ophthalmol; 2016 Jun; 94(4):358-64. PubMed ID: 26285163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
    Zhao XY; Xia S; Chen YX
    Br J Ophthalmol; 2018 Aug; 102(8):1077-1085. PubMed ID: 29246890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial.
    Li S; Guo L; Zhou P; Tang J; Wang Z; Zhang L; Zhao M; Qu J
    Eye Vis (Lond); 2022 Dec; 9(1):44. PubMed ID: 36451252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Intravitreal Ranibizumab on the Surgical Outcome for Diabetic Retinopathy With Tractional Retinal Detachment.
    Dong F; Yu C; Ding H; Shen L; Lou D
    Medicine (Baltimore); 2016 Feb; 95(8):e2731. PubMed ID: 26937902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.
    Dervenis P; Dervenis N; Smith JM; Steel DH
    Cochrane Database Syst Rev; 2023 May; 5(5):CD008214. PubMed ID: 37260074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy.
    Lu Q; Lu L; Chen B; Chen W; Lu P
    Can J Ophthalmol; 2019 Jun; 54(3):291-296. PubMed ID: 31109466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY.
    Su L; Ren X; Wei H; Zhao L; Zhang X; Liu J; Su C; Tan L; Li X
    Retina; 2016 May; 36(5):938-43. PubMed ID: 26630313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy.
    Xu J; Zhao M; Li JP; Liu NP
    BMC Ophthalmol; 2020 Apr; 20(1):149. PubMed ID: 32295566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.
    Takayama K; Someya H; Yokoyama H; Kimura T; Takamura Y; Morioka M; Terasaki H; Ueda T; Ogata N; Kitano S; Tashiro M; Sakamoto T; Takeuchi M
    PLoS One; 2021; 16(10):e0258415. PubMed ID: 34624063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the effects of ranibizumab as a pretreatment for vitrectomy in proliferative diabetic retinopathy: a retrospective cohort study.
    Zhou HW; Chen K
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5939-5945. PubMed ID: 36066170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
    Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
    Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy.
    Guan J; Cai N; Liu LM; Zhao N; Liu NN
    Diabetes Ther; 2020 Jun; 11(6):1397-1406. PubMed ID: 32356244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.